Hyperferritinemia is another surrogate marker of advanced liver disease

May 13, 2009

High serum ferritin, being a hallmark of hereditary hemochromatosis , is frequently found in chronic hepatitis C, alcoholic or non-alcoholic steatohepatitis and non-alcoholic fatty liver disease patients . A study in Italy has investigated the link between ferritin and steatosis in a non-obese cohort of non-alcoholic patients. In southern European populations, high ferritin levels, after exclusion of diagnosis of HH, represent a risk factor for steatosis and clinical relevance, being associated with low platelet count.

Patients with chronic (HCV) infection often have elevated serum iron indices, but these do not accurately reflect hepatic iron content, nor are they able to predict clinically important endpoints, such as progression of fibrosis and responsiveness to interferon-based regimens. Studies that attempt to link iron and the course of chronic hepatitis C have been inconclusive. In C, steatosis is a common histological finding, occurring in 30%-70% of such patients. The biological mechanism underlying steatosis in HCV infection is not definitively understood, and is considered to be multifactorial with metabolic mechanisms, including insulin resistance and overload.

A research article to be published on May 7, 2009 in the World Journal of Gastroenterology addresses this question. The research team led by Professor Licata from Gastroenterology and Hepatology Unit of Palermo University analyzed in a cross-sectional study, a cohort of non-obese, non-alcoholic patients with compensated chronic liver disease characterized by elevated serum ferritin levels, of varying etiology, excluding hemochromatosis, to reassess the link between hyperferritinemia and other markers of the metabolic syndrome, mainly steatosis. All data provide further evidence that hyperferritinemia might be another surrogate marker of advanced liver disease of any etiology.

More information: Licata A, Nebbia ME, Cabibbo G, Lo Iacono G, Barbaria F, Brucato V, Alessi N, Porrovecchio S, Di Marco V, Craxě A, Cammà C. Hyperferritinemia is a risk factor for steatosis in chronic . World J Gastroenterol 2009; 15(17): 2132-2138 http://www.wjgnet.com/1007-9327/15/2132.asp

Source: World Journal of Gastroenterology (news : web)

Explore further: Ebola in mind, US colleges screen some students

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Ebola in mind, US colleges screen some students

57 minutes ago

University students from West Africa may be subject to extra health checks when they arrive to study in the United States as administrators try to insulate their campuses from the worst Ebola outbreak in ...

Senegal confirms its first case of Ebola (Update)

1 hour ago

A man infected with Ebola traveled to Senegal, becoming the first recorded in this country of an outbreak that has hit four other West African countries and has killed more than 1,500 people, the Ministry ...

WHO: More Ebola cases in past week than any other

2 hours ago

The past week has seen the highest increase of Ebola cases since the outbreak in West Africa began, the World Health Organization said Friday, offering more evidence that the crisis is worsening.

Guidelines presented for diagnosing focal liver lesions

17 hours ago

(HealthDay)—Focal liver lesions (FLLs) are mostly benign, and can be diagnosed based on knowledge of their presentation, associated clinical and laboratory features, and natural history, according to clinical ...

User comments : 0